Prostate Cancer: Improved Patient Care in the Age of Advancing Theranostics
- 1 August 2024
- journal article
- editorial
- Published by Radiological Society of North America (RSNA) in Radiology
- Vol. 312 (2) , e241564
Abstract
No abstract availableThis publication has 5 references indexed in Scilit:
- Pharmacokinetic Comparison of Selective Prostatic Arterial and Intravenous PSMA PET/CT Radioligand Infusions in Primary Prostatic AdenocarcinomaRadiology, 2024
- PSMA PET Parameters for Predicting Outcomes in Patients with Prostate CancerRadiology, 2023
- Reawakening of Nuclear Medicine through Molecular Imaging: Quantitative Theranostics and PSMA PETRadiology, 2023
- Development of [177Lu]Lu-LNC1003 for radioligand therapy of prostate cancer with a moderate level of PSMA expressionEuropean Journal of Nuclear Medicine and Molecular Imaging, 2023
- Intraindividual Comparison of Selective Arterial versus Venous 68Ga-DOTATOC PET/CT in Patients with Gastroenteropancreatic Neuroendocrine TumorsClinical Cancer Research, 2010